C. Coppin

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

D. Osoba, I. Tannock, M. Stockler, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.

K. Gelmon, D. Ayers, A. Tolcher, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.

D. Osoba, I. Tannock, K. Murphy, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

I. Tannock, L. Sullivan, M. Gospodarowicz, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.